These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 32319657)

  • 1. Long non‑coding RNA GHET1 promotes osteosarcoma development and progression via Wnt/β‑catenin signaling pathway.
    Chen X; Zhao W; Fan W
    Oncol Rep; 2020 Jul; 44(1):349-359. PubMed ID: 32319657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA‑CASC15 promotes osteosarcoma proliferation and metastasis by regulating epithelial‑mesenchymal transition via the Wnt/β‑catenin signaling pathway.
    Wang H; Zhang P
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
    Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA CRNDE is activated by SP1 and promotes osteosarcoma proliferation, invasion, and epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway.
    Ding Q; Mo F; Cai X; Zhang W; Wang J; Yang S; Liu X
    J Cell Biochem; 2020 Jun; 121(5-6):3358-3371. PubMed ID: 31898343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of MALAT1 inhibits osteosarcoma progression via regulating the miR‑34a/cyclin D1 axis.
    Duan G; Zhang C; Xu C; Xu C; Zhang L; Zhang Y
    Int J Oncol; 2019 Jan; 54(1):17-28. PubMed ID: 30365098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nasopharyngeal carcinoma‑associated gene 6 inhibits cell viability, migration, invasion and induces apoptosis in osteosarcoma cells by inactivating the Wnt/β‑catenin signaling pathway.
    Liu L; Wang R; Zhang Z; Wang X
    Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC01128 regulates the development of osteosarcoma by sponging miR-299-3p to mediate MMP2 expression and activating Wnt/β-catenin signalling pathway.
    Yao Q; Chen T
    J Cell Mol Med; 2020 Dec; 24(24):14293-14305. PubMed ID: 33108067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-425-5p decreases LncRNA MALAT1 and TUG1 expressions and suppresses tumorigenesis in osteosarcoma via Wnt/β-catenin signaling pathway.
    Yang G; Zhang C; Wang N; Chen J
    Int J Biochem Cell Biol; 2019 Jun; 111():42-51. PubMed ID: 30986552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TUG1 promotes osteosarcoma tumorigenesis by upregulating EZH2 expression via miR-144-3p.
    Cao J; Han X; Qi X; Jin X; Li X
    Int J Oncol; 2017 Oct; 51(4):1115-1123. PubMed ID: 28902349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulated lnc-SNHG1 contributes to osteosarcoma progression through sequestration of miR-577 and activation of WNT2B/Wnt/β-catenin pathway.
    Jiang Z; Jiang C; Fang J
    Biochem Biophys Res Commun; 2018 Jan; 495(1):238-245. PubMed ID: 29108989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA AFAP1‑AS1 enhances cell proliferation and invasion in osteosarcoma through regulating miR‑4695‑5p/TCF4‑β‑catenin signaling.
    Li R; Liu S; Li Y; Tang Q; Xie Y; Zhai R
    Mol Med Rep; 2018 Aug; 18(2):1616-1622. PubMed ID: 29901121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of miR‑214 promotes the progression of human osteosarcoma by regulating the Wnt/β‑catenin signaling pathway.
    Zhu XB; Zhang ZC; Han GS; Han JZ; Qiu DP
    Mol Med Rep; 2017 Apr; 15(4):1884-1892. PubMed ID: 28260089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA nuclear-enriched abundant transcript 1 promotes cell proliferation and invasion by targeting miR-186-5p/HIF-1α in osteosarcoma.
    Tan H; Zhao L
    J Cell Biochem; 2019 Apr; 120(4):6502-6514. PubMed ID: 30485482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA KCNQ1OT1 contributes to tumor growth and activates Wnt/β‑catenin signaling in osteosarcoma by targeting the miR‑3666/KLF7 axis.
    Huang A; Jin S; Han W; Wang Y; Ma S; Wang Z; Lin K; Zou Q; Zhou J; Li Z; Chen L
    Int J Mol Med; 2021 Jan; 47(1):387-396. PubMed ID: 33416089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpressing circular RNA hsa_circ_0002052 impairs osteosarcoma progression via inhibiting Wnt/β-catenin pathway by regulating miR-1205/APC2 axis.
    Wu Z; Shi W; Jiang C
    Biochem Biophys Res Commun; 2018 Aug; 502(4):465-471. PubMed ID: 29852168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage-derived CCL18 promotes osteosarcoma proliferation and migration by upregulating the expression of UCA1.
    Su Y; Zhou Y; Sun YJ; Wang YL; Yin JY; Huang YJ; Zhang JJ; He AN; Han K; Zhang HZ; Yao Y; Lv XB; Hu HY
    J Mol Med (Berl); 2019 Jan; 97(1):49-61. PubMed ID: 30426155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway.
    Shi D; Wu F; Mu S; Hu B; Zhong B; Gao F; Qing X; Liu J; Zhang Z; Shao Z
    J Exp Clin Cancer Res; 2019 Aug; 38(1):375. PubMed ID: 31443665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticancer effects of melatonin via regulating lncRNA JPX-Wnt/β-catenin signalling pathway in human osteosarcoma cells.
    Li Y; Zou J; Li B; Du J
    J Cell Mol Med; 2021 Oct; 25(20):9543-9556. PubMed ID: 34547170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA AWPPH promotes osteosarcoma progression via activation of Wnt/β-catenin pathway through modulating miR-93-3p/FZD7 axis.
    Li C; Wang F; Wei B; Wang L; Kong D
    Biochem Biophys Res Commun; 2019 Jun; 514(3):1017-1022. PubMed ID: 31092328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circular RNA circTADA2A promotes osteosarcoma progression and metastasis by sponging miR-203a-3p and regulating CREB3 expression.
    Wu Y; Xie Z; Chen J; Chen J; Ni W; Ma Y; Huang K; Wang G; Wang J; Ma J; Shen S; Fan S
    Mol Cancer; 2019 Apr; 18(1):73. PubMed ID: 30940151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.